Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
Sitagliptin
Medication labelJANUVIA® is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Limitations of…
Why this: Advisory · dailymed-prescription
JANUVIA® is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Limitations of Use JANUVIA should not be used in patients with type 1 diabetes. JANUVIA has not been studied in patients with a history of pancreatitis. It is unknown whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis while using JANUVIA. [See Warnings and Precautions (5.1).]
- generic_name
- sitagliptin
- product_names
- sitagliptin
- ndc
- 50090-3527, 0006-0221, 50090-3527-1, 50090-3527-0
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en